{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:41:18Z","timestamp":1788932478967,"version":"build-2803163510"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008081","name":"DEBRA UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008081","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inherited epidermolysis bullosa (EB) is a cluster of rare, genetic skin and mucosal fragility disorders with multi-system and secondary effects, in which blistering and erosions occur in response to friction\/mechanical trauma. Considering the incurable and potentially life-limiting nature of the condition and the challenges posed by its symptoms, a palliative approach to EB-related care is necessary. However, knowledge and experience related to the provision of EB palliative care is minimal. Evidence-based, best care guidelines are needed to establish a base of knowledge for practitioners to prevent or ease suffering while improving comfort at all stages of the illness, not just the end of life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This consensus guideline (CG) was begun at the request of DEBRA International, an international organization dedicated to improvement of care, research, and dissemination of knowledge for EB patients, and represents the work of an international panel of medical experts in palliative care and EB, people living with EB, and people who provide care for individuals living with EB. Following a rigorous, evidence-based guideline development process, the author panel identified six clinical outcomes based on the results of a survey of people living with EB, carers, and medical experts in the field, as well as an exhaustive and systematic evaluation of literature. Recommendations for the best clinical provision of palliative care for people living with EB for each of the outcomes were reached through panel consensus of the available literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This article presents evidence-based recommendations for the provision of palliative healthcare services that establishes a base of knowledge and practice for an interdisciplinary team approach to ease suffering and improve the quality of life for all people living with EB. Any specific differences in the provision of care between EB subtypes are noted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Because there is yet no cure for EB, this evidence-based CG is a means of optimizing and standardizing the IDT care needed to reduce suffering while improving comfort and overall quality of life for people living with this rare and often devastating condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02870-8","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T11:02:33Z","timestamp":1693825353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Consensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis bullosa"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-6848","authenticated-orcid":false,"given":"Mark P.","family":"Popenhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Blishen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilini","family":"Rajapakse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Pellicer Arasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina","family":"Ferreira da Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie","family":"Badger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasta","family":"Zmazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Ambreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harper","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kattya","family":"Mayre-Chilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"issue":"4","key":"2870_CR1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, Bauer J, Bodemer C, Bolling M, Bruckner-Tuderman L, Diem A, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614\u201327.","journal-title":"Br J Dermatol"},{"issue":"2","key":"2870_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clnu.2019.02.023","volume":"39","author":"S Salera","year":"2020","unstructured":"Salera S, Tadini G, Rossetti D, Grassi F, Marchisio P, Agostoni C, et al. A nutrition-based approach to epidermolysis bullosa: causes, assessments, requirements and management. Clin Nutr. 2020;39(2):343\u201352.","journal-title":"Clin Nutr"},{"key":"2870_CR3","doi-asserted-by":"crossref","unstructured":"World Health Organization. Palliative care 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care. Accessed 30 July 2022.","DOI":"10.1093\/med\/9780198862994.003.0005"},{"key":"2870_CR4","unstructured":"MedlinePlus [Internet]. Bethesda (MD): National library of medicine (US). Palliative care 2015. https:\/\/medlineplus.gov\/palliativecare.html. Accessed 30 July 2022."},{"key":"2870_CR5","unstructured":"National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care. Richmond, VA: National Coalition for Hospice and Palliative Care; 2018. Available from: https:\/\/www.nationalcoalitionhpc.org\/ncp."},{"key":"2870_CR6","unstructured":"National Institutes of Health. Frequently asked questions about palliative care 2021. https:\/\/www.nia.nih.gov\/health\/frequently-asked-questions-about-palliative-care. Accessed 30 July 2022."},{"key":"2870_CR7","volume-title":"GRADEpro GDT: GRADEpro guideline development tool","author":"I Evidence Prime","year":"2020","unstructured":"Evidence Prime I. GRADEpro GDT: GRADEpro guideline development tool. Hamilton: McMaster University; 2020."},{"issue":"2","key":"2870_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/pde.12258","volume":"31","author":"R Ahmad","year":"2014","unstructured":"Ahmad R, Bruckner A. A survey of epidermolysis bullosa care in the United States and Canada. Pediatr Dermatol. 2014;31(2):169\u201375.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"2870_CR9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.14104","volume":"174","author":"J Mellerio","year":"2016","unstructured":"Mellerio J, Robertson S, Bernardis C, Diem A, Fine J, George R, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol. 2016;174(1):56\u201367.","journal-title":"Br J Dermatol"},{"issue":"1","key":"2870_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13023-019-1086-5","volume":"14","author":"K Martin","year":"2019","unstructured":"Martin K, Geuens S, Asche J, Bodan R, Browne F, Downe A, et al. Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines. Orphanet J Rare Dis. 2019;14(1):133.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2870_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2478\/aiht-2018-69-3072","volume":"69","author":"H Lali\u0107","year":"2018","unstructured":"Lali\u0107 H. Discrepancies in the evaluation of incapacity for work in a patient with epidermolysis bullosa acquisita between public pension fund and occupational medicine expert raise the issue of competencies. Arh Hig Rada Toksikol. 2018;69(1):77\u201380.","journal-title":"Arh Hig Rada Toksikol"},{"issue":"4","key":"2870_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10880-010-9205-4","volume":"17","author":"F Margari","year":"2010","unstructured":"Margari F, Lecce P, Santamato W, Ventura P, Sportelli N, Annicchiarico G, et al. Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. J Clin Psychol Med Settings. 2010;17(4):333\u20139.","journal-title":"J Clin Psychol Med Settings"},{"issue":"11","key":"2870_CR13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.12968\/jowc.2012.21.11.528","volume":"21","author":"T Adni","year":"2012","unstructured":"Adni T, Martin K, Mudge E. The psychosocial impact of chronic wounds on patients with severe epidermolysis bullosa. J Wound Care. 2012;21(11):528\u201338.","journal-title":"J Wound Care"},{"issue":"1","key":"2870_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/JDN.0000000000000187","volume":"8","author":"K Tan","year":"2016","unstructured":"Tan K, Foo P, Leow M. Nursing management of a young child with epidermolysis bullosa simplex: dowling-meara in Singapore. J Dermatol Nurses Assoc. 2016;8(1):59\u201363.","journal-title":"J Dermatol Nurses Assoc."},{"issue":"1","key":"2870_CR15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JDN.0000000000000188","volume":"8","author":"R Bod\u00e1n","year":"2016","unstructured":"Bod\u00e1n R. Epidermolysis bullosa: an insider\u2019s perspective to a rare genetic connective tissue disorder. J Dermatol Nurses Assoc. 2016;8(1):46\u201356.","journal-title":"J Dermatol Nurses Assoc"},{"issue":"2\u20133","key":"2870_CR16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.healthpol.2012.02.018","volume":"105","author":"K Budych","year":"2012","unstructured":"Budych K, Helms T, Schultz C. How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction. Health Policy. 2012;105(2\u20133):154\u201364.","journal-title":"Health Policy"},{"key":"2870_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/IJGM.S180464","volume":"11","author":"A Hubail","year":"2018","unstructured":"Hubail A, Belkharoeva R, Tepluk N, Grabovskaya O. A case of a patient with severe epidermolysis bullosa surviving to adulthood. Int J Gen Med. 2018;11:413\u201321.","journal-title":"Int J Gen Med"},{"issue":"2","key":"2870_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1540-9740.2004.03008.x","volume":"3","author":"K Al Hawsawi","year":"2004","unstructured":"Al Hawsawi K, Al Aboud K, Wolf R. Misconceptions surrounding genetic diseases in developing countries. Skinmed. 2004;3(2):107.","journal-title":"Skinmed"},{"issue":"6","key":"2870_CR19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/1049732311400431","volume":"21","author":"E Dures","year":"2011","unstructured":"Dures E, Morris M, Gleeson K, Rumsey N. The psychosocial impact of epidermolysis bullosa. Qual Health Res. 2011;21(6):771\u201382.","journal-title":"Qual Health Res"},{"issue":"5","key":"2870_CR20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40257-014-0091-7","volume":"15","author":"C Yang","year":"2014","unstructured":"Yang C, Kroshinksy D, Cummings B. Neonatal junctional epidermolysis bullosa: treatment conundrums and ethical decision making. Am J Clin Dermatol. 2014;15(5):445\u201350.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"2870_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0043-104205","volume":"56","author":"R Stachow","year":"2017","unstructured":"Stachow R, K\u00fcppers-Chinnow M, Scheewe S. Rehabilitation von kindern und jugendlichen mit chronischen hauterkrankungen [rehabilitation of children and adolescents with chronic skin diseases]. Rehabil (Stuttg). 2017;56(2):127\u201340.","journal-title":"Rehabil (Stuttg)"},{"issue":"7","key":"2870_CR22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1089\/jpm.2018.0054","volume":"21","author":"K Pasichow","year":"2018","unstructured":"Pasichow K, Frizzola M, Miller E. Palliative sedation with oral medicines in an infant with generalized severe junctional epidermolysis bullosa. J Palliat Med. 2018;21(7):1048\u201352.","journal-title":"J Palliat Med"},{"issue":"3","key":"2870_CR23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/1049732314549029","volume":"25","author":"L Hubbard","year":"2015","unstructured":"Hubbard L, Mayre-Chilton K. Quality of life among adults with epidermolysis bullosa living with a gastrostomy tube since childhood. Qual Health Res. 2015;25(3):310\u20139.","journal-title":"Qual Health Res"},{"issue":"1","key":"2870_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/pde.12391","volume":"32","author":"C Danial","year":"2015","unstructured":"Danial C, Adeduntan R, Gorell E, Lucky A, Paller A, Bruckner A, et al. Prevalence and characterization of pruritus in epidermolysis bullosa. Pediatr Dermatol. 2015;32(1):53\u20139.","journal-title":"Pediatr Dermatol"},{"key":"2870_CR25","volume-title":"Best practice guidelines for skin and wound care in epidermolysis bullosa. An International Consensus","author":"J Denyer","year":"2017","unstructured":"Denyer J, Pillay E, Clapham J. Best practice guidelines for skin and wound care in epidermolysis bullosa. An International Consensus. London: Wounds International; 2017."},{"key":"2870_CR26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12916-014-0178-2","volume":"12","author":"K Goldschneider","year":"2014","unstructured":"Goldschneider K, Good J, Harrop E, Liossi C, Lynch-Jordan A, Martinez A, et al. Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med. 2014;12:178.","journal-title":"BMC Med"},{"key":"2870_CR27","unstructured":"Danial C, Adeduntan R, Gorell E, Lucky A, Paller A, Bruckner A, et al. Patients with epidermolysis bullosa identify pruritus as a greater problem than pain. In: 39th Annual meeting of the society for pediatric dermatology; Milwaukee, WI, USA: Pediatr Dermatol. 2013. p. 642\u20133."},{"issue":"3","key":"2870_CR28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2340\/00015555-2827","volume":"98","author":"N Schr\u00e4der","year":"2018","unstructured":"Schr\u00e4der N, Yuen W, Jonkman M. Pain quality assessment scale for epidermolysis bullosa. Acta Derm Venereol. 2018;98(3):346\u20139.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"2870_CR29","first-page":"AB132","volume":"79","author":"A Bardhan","year":"2018","unstructured":"Bardhan A, James L, O\u2019Sullivan M, Heagerty A. Epidermolysis bullosa and gait analysis: one big step toward improving quality of life. J Am Acad Dermatol. 2018;79(3):AB132.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"2870_CR30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2340\/00015555-3179","volume":"99","author":"P Mauritz","year":"2019","unstructured":"Mauritz P, Jonkman M, Visser S, Finkenauer C, Duipmans J, Hagedoorn M. Impact of painful wound care in epidermolysis bullosa during childhood: an interview study with adult patients and parents. Acta Derm Venereol. 2019;99(9):783\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"2870_CR31","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0022-5347(01)63291-9","volume":"159","author":"D Glazier","year":"1998","unstructured":"Glazier D, Zaontz M. Epidermolysis bullosa: a review of the associated urological complications. J Urol. 1998;159(6):2122\u20135.","journal-title":"J Urol"},{"key":"2870_CR32","unstructured":"Lee B, Tan J, Radjenovic M, Tat L, Coroneo M, Murrell D. Prospective study on the ocular manifestations in inherited epidermolysis bullosa. Australas J Dermatol. 2018;59."},{"issue":"3","key":"2870_CR33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/09273948.2019.1587472","volume":"28","author":"R Rashad","year":"2020","unstructured":"Rashad R, Weed MC, Quinn N, Chen VM. Extended wear bandage contact lenses decrease pain and preserve vision in patients with epidermolysis bullosa: case series and review of literature. Ocul Immunol Inflamm. 2020;28(3):379\u201383.","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"2870_CR34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2230.2011.04091.x","volume":"36","author":"L Hubbard","year":"2011","unstructured":"Hubbard L, Haynes L, Sklar M, Martinez A, Mellerio J. The challenges of meeting nutritional requirements in children and adults with epidermolysis bullosa: proceedings of a multidisciplinary team study day. Clin Exp Dermatol. 2011;36(6):579\u201383.","journal-title":"Clin Exp Dermatol"},{"key":"2870_CR35","unstructured":"Anderson BT, Brumbaugh DE, Narkewicz MR, Kramer RE. Endoscopic management of esophageal strictures in children with epidermolysis bullosa. World Congress of Pediatric Gastroenterology, Hepatology and Nutrition; Montreal, QC, Canada: J Pediatr Gastroenterol Nutr; 2016. p. S316."},{"issue":"4","key":"2870_CR36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1213\/ANE.0000000000005749","volume":"134","author":"M Brooks Peterson","year":"2022","unstructured":"Brooks Peterson M, Strupp K, Brockel M, Wilder M, Zieg J, Bruckner A, et al. Anesthetic management and outcomes of patients with epidermolysis bullosa: experience at a tertiary referral center. Anesth Analg. 2022;134(4):810\u201321.","journal-title":"Anesth Analg"},{"issue":"4","key":"2870_CR37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/ACO.0b013e32833bb50b","volume":"23","author":"A Gottschalk","year":"2010","unstructured":"Gottschalk A, Venherm S, Vowinkel T, T\u00fcbergen D, Frosch M, Hahnenkamp K. Anesthesia for balloon dilatation of esophageal strictures in children with epidermolysis bullosa dystrophica: from intubation to sedation. Curr Opin Anaesthesiol. 2010;23(4):518\u201322.","journal-title":"Curr Opin Anaesthesiol"},{"key":"2870_CR38","unstructured":"Hubbard L, Jones R. Preventative nutritional care guideline: Constipation management for children and adults with epidermolysis bullosa. 2019. https:\/\/af13d689-15eb-4199-8733-e91a7bb8ae3f.usrfiles.com\/ugd\/af13d6_ef4673a60a34476093489b47bc5b0921.pdf. Accessed 3 Oct, 2021."},{"issue":"1","key":"2870_CR39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13023-022-02448-w","volume":"18","author":"C Liy-Wong","year":"2023","unstructured":"Liy-Wong C, Tarango C, Pope E, Coates T, Bruckner AL, Feinstein J, et al. Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa. Orphanet J Rare Dis. 2023;18(1):38.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2870_CR40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1525-1470.2011.01612.x","volume":"29","author":"L Haynes","year":"2012","unstructured":"Haynes L, Mellerio J, Martinez A. Gastrostomy tube feeding in children with epidermolysis bullosa: consideration of key issues. Pediatr Dermatol. 2012;29(3):277\u201384.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"2870_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bjd.16139","volume":"179","author":"A Zidorio","year":"2018","unstructured":"Zidorio A, Dutra E, Castro L, Carvalho K. Effectiveness of gastrostomy for improving nutritional status and quality of life in patients with epidermolysis bullosa: a systematic review. Br J Dermatol. 2018;179(1):42\u20139.","journal-title":"Br J Dermatol"},{"key":"2870_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/scd.12511","volume":"40","author":"S Kr\u00e4mer","year":"2020","unstructured":"Kr\u00e4mer S, Lucas J, Gamboa F, Pe\u00f1arrocha Diago M, Pe\u00f1arrocha Oltra D, Guzm\u00e1n-Letelier M, et al. Clinical practice guidelines: oral health care for children and adults living with epidermolysis bullosa. Spec Care Dentist. 2020;40:3\u201381.","journal-title":"Spec Care Dentist"},{"issue":"2","key":"2870_CR43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2133.2012.10997.x","volume":"167","author":"W Yuen","year":"2012","unstructured":"Yuen W, Duipmans J, Molenbuur B, Herpertz I, Mandema J, Jonkman M. Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa. Br J Dermatol. 2012;167(2):374\u201382.","journal-title":"Br J Dermatol"},{"issue":"4","key":"2870_CR44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jpeds.2011.09.029","volume":"160","author":"J Ida","year":"2012","unstructured":"Ida J, Livshitz I, Azizkhan R, Lucky A, Elluru R. Upper airway complications of junctional epidermolysis bullosa. J Pediatr. 2012;160(4):657\u201361.","journal-title":"J Pediatr"},{"issue":"5","key":"2870_CR45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.siny.2014.08.002","volume":"19","author":"A Verhagen","year":"2014","unstructured":"Verhagen A. Neonatal euthanasia: lessons from the Groningen protocol. Semin Fetal Neonatal Med. 2014;19(5):296\u20139.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"5","key":"2870_CR46","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/iwj.12394","volume":"13","author":"L Stevens","year":"2016","unstructured":"Stevens L, McKenna S, Marty J, Cowin A, Kopecki Z. Understanding the outcomes of a home nursing programme for patients with epidermolysis bullosa: an Australian perspective. Int Wound J. 2016;13(5):863\u20139.","journal-title":"Int Wound J"},{"issue":"1","key":"2870_CR47","doi-asserted-by":"crossref","first-page":"e20173977","DOI":"10.1542\/peds.2017-3977","volume":"142","author":"S Berman","year":"2018","unstructured":"Berman S. The importance of attending patient funerals. Pediatrics. 2018;142(1):e20173977.","journal-title":"Pediatrics"},{"issue":"2","key":"2870_CR48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/hex.13006","volume":"23","author":"S Kearney","year":"2020","unstructured":"Kearney S, Donohoe A, McAuliffe E. Living with epidermolysis bullosa: daily challenges and health-care needs. Health Expect. 2020;23(2):368\u201376.","journal-title":"Health Expect"},{"issue":"6","key":"2870_CR49","doi-asserted-by":"crossref","first-page":"e20191130","DOI":"10.1542\/peds.2019-1130","volume":"144","author":"J deSante-Bertkau","year":"2019","unstructured":"deSante-Bertkau J, Shubkin C, Nelson W, Salter E, Lantos J. When specialty care is unavailable to rural families. Pediatrics. 2019;144(6):e20191130.","journal-title":"Pediatrics"},{"issue":"6","key":"2870_CR50","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2133.2009.09347.x","volume":"161","author":"J Frew","year":"2009","unstructured":"Frew J, Martin L, Nijsten T, Murrell D. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol. 2009;161(6):1323\u201330.","journal-title":"Br J Dermatol"},{"issue":"7","key":"2870_CR51","doi-asserted-by":"crossref","first-page":"A516","DOI":"10.1016\/j.jval.2012.08.1768","volume":"15","author":"R Linertov\u00e1","year":"2012","unstructured":"Linertov\u00e1 R, L\u00f3pez-Bastida J, Serrano-Aguilar P, Posada-de-la-Paz M. Social economic burden and health-related quality of life in patients with rare diseases in Europe (BURQOL-RD project) Spanish results. Value Health. 2012;15(7):A516.","journal-title":"Value Health"},{"issue":"5","key":"2870_CR52","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.jid.2019.03.1011","volume":"139","author":"V Eng","year":"2019","unstructured":"Eng V, Solis D, Choi S, Nazaroff J, Li S, Tang J. Clinical manifestations and quality of life in patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2019;139(5):S161.","journal-title":"J Invest Dermatol"},{"key":"2870_CR53","first-page":"ii467","volume":"27","author":"B Kortus-G\u00f6tze","year":"2012","unstructured":"Kortus-G\u00f6tze B, H\u00f6ferh\u00fcsch T, Hoyer J. Peritoneal dialysis in a patient with severe recessive dystrophic epidermolysis bullosa. Nephrol Dial Transplant. 2012;27:ii467.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2870_CR54","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ad.2017.01.015","volume":"108","author":"A Batalla","year":"2017","unstructured":"Batalla A, Vicente A, Bartrons J, Prada F, Fortuny C, Gonz\u00e1lez-Ense\u00f1at M. Cardiomyopathy in patients with hereditary bullous epidermolysis. Actas Dermosifiliogr. 2017;108(6):544\u20139.","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"2870_CR55","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/ijd.12819","volume":"55","author":"T Cestari","year":"2016","unstructured":"Cestari T, Prati C, Menegon D, Prado Oliveira Z, Machado M, Dumet J, et al. Translation, cross-cultural adaptation and validation of the quality of life evaluation in epidermolysis bullosa instrument in Brazilian Portuguese. Int J Dermatol. 2016;55(2):e94\u20139.","journal-title":"Int J Dermatol"},{"issue":"1","key":"2870_CR56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijwd.2017.11.004","volume":"4","author":"S Jain","year":"2018","unstructured":"Jain S, Murrell D. Psychosocial impact of inherited and autoimmune blistering diseases. Int J Womens Dermatol. 2018;4(1):49\u201353.","journal-title":"Int J Womens Dermatol"},{"issue":"6","key":"2870_CR57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ad.2010.03.002","volume":"101","author":"A Hern\u00e1ndez-Mart\u00edn","year":"2010","unstructured":"Hern\u00e1ndez-Mart\u00edn A, Torrelo A. Epiderm\u00f3lisis ampollosas hereditarias: del diagn\u00f3stico a la realidad [Inherited epidermolysis bullosa: from diagnosis to reality]. Actas Dermosifiliogr. 2010;101(6):495\u2013505.","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"2870_CR58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2214.1986.tb00504.x","volume":"12","author":"R Lansdown","year":"1986","unstructured":"Lansdown R, Atherton D, Dale A, Sproston S, Lloyd J. Practical and psychological problems for parents of children with epidermolysis bullosa. Child Care Health Dev. 1986;12(4):251\u20136.","journal-title":"Child Care Health Dev"},{"issue":"3","key":"2870_CR59","first-page":"211","volume":"102","author":"D M\u0105cik","year":"2015","unstructured":"M\u0105cik D, Kowalska-D\u0105browska M. The need of social support, life attitudes and life satisfaction among parents of children suffering from epidermolysis bullosa. Przegl Dermatol. 2015;102(3):211\u201320.","journal-title":"Przegl Dermatol"},{"issue":"1","key":"2870_CR60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13023-021-01702-x","volume":"16","author":"P Mauritz","year":"2021","unstructured":"Mauritz P, Bolling M, Duipmans J, Hagedoorn M. The relationship between quality of life and coping strategies of children with EB and their parents. Orphanet J Rare Dis. 2021;16(1):53.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2870_CR61","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","volume":"16","author":"S Tabolli","year":"2009","unstructured":"Tabolli S, Sampogna F, Di Pietro C, Paradisi A, Uras C, Zotti P, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol. 2009;16(1):869\u201377.","journal-title":"Br J Dermatol"},{"issue":"1","key":"2870_CR62","first-page":"46","volume":"13","author":"A Downe","year":"2017","unstructured":"Downe A. The effect of current economic cuts to wound dressings and its impact on patients with epidermolysis bullosa: a case study. Wounds UK. 2017;13(1):46\u201353.","journal-title":"Wounds UK"},{"issue":"6","key":"2870_CR63","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/bjd.14072","volume":"173","author":"H Dufresne","year":"2015","unstructured":"Dufresne H, Hadj-Rabia S, Taieb C, Bodemer C. Development and validation of an epidermolysis bullosa family\/parental burden score. Br J Dermatol. 2015;173(6):1405\u201310.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"2870_CR64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10198-016-0783-4","volume":"17","author":"A Angelis","year":"2016","unstructured":"Angelis A, Kanavos P, L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Serrano-Aguilar P, et al. Social\/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. Eur J Health Econ. 2016;17(Suppl 1):31\u201342.","journal-title":"Eur J Health Econ"},{"key":"2870_CR65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2340\/00015555-2263","volume":"96","author":"S Marron","year":"2016","unstructured":"Marron S, Tomas-Aragones L, Lamarre M, Cordoba-Irusta T. Psychosocial history and intervention of female patient with epidermolysis bullosa. Acta Derm Venereol. 2016;96:139.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"2870_CR66","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaad.2013.04.053","volume":"69","author":"JW Frew","year":"2013","unstructured":"Frew JW, Cepeda Valdes R, Fortuna G, Murrell DF, Salas AJ. Measuring quality of life in epidermolysis bullosa in Mexico: cross-cultural validation of the hispanic version of the quality of life in epidermolysis Bullosa questionnaire. J Am Acad Dermatol. 2013;69(4):652\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2870_CR67","first-page":"AB94","volume":"60","author":"S Chee","year":"2009","unstructured":"Chee S, Murrell D. A comparison of dermatology life quality Index scores in a dermatology practice setting. J Am Acad Dermatol. 2009;60(3):AB94.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2870_CR68","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s11136-020-02495-5","volume":"29","author":"C Togo","year":"2020","unstructured":"Togo C, Zidorio A, Gon\u00e7alves V, Hubbard L, de Carvalho K, Dutra E. Quality of life in people with epidermolysis bullosa: a systematic review. Qual Life Res. 2020;29(7):1731\u201345.","journal-title":"Qual Life Res"},{"issue":"9","key":"2870_CR69","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1468-3083.2012.04682.x","volume":"27","author":"F Sampogna","year":"2013","unstructured":"Sampogna F, Tabolli S, Di Pietro C, Castiglia D, Zambruno G, Abeni D. The evaluation of family impact of recessive dystrophic epidermolysis bullosa using the Italian version of the family dermatology life quality index. J Eur Acad Dermatol Venereol. 2013;27(9):1151\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"2870_CR70","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/jdv.14288","volume":"31","author":"F Sampogna","year":"2017","unstructured":"Sampogna F, Finlay A, Salek S, Chernyshov P, Dalgard F, Evers A, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2017;31(9):1429\u201339.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2870_CR71","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/1040-3590.15.4.532","volume":"15","author":"U Stangier","year":"2003","unstructured":"Stangier U, Ehlers A, Gieler U. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess. 2003;15(4):532\u201349.","journal-title":"Psychol Assess"},{"issue":"1","key":"2870_CR72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/JDN.0000000000000514","volume":"12","author":"R Bod\u00e1n","year":"2020","unstructured":"Bod\u00e1n R. Reframing the care of children with epidermolysis bullosa through the lens of medical trauma. J Dermatol Nurses Assoc. 2020;12(1):16\u201323.","journal-title":"J Dermatol Nurses Assoc"},{"issue":"5","key":"2870_CR73","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/1359105310387954","volume":"16","author":"E Williams","year":"2011","unstructured":"Williams E, Gannon K, Soon K. The experiences of young people with epidermolysis bullosa simplex: a qualitative study. J Health Psychol. 2011;16(5):701\u201310.","journal-title":"J Health Psychol"},{"issue":"5","key":"2870_CR74","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1365-2133.2004.06339.x","volume":"152","author":"J Fine","year":"2005","unstructured":"Fine J, Johnson L, Weiner M, Suchindran C. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br J Dermatol. 2005;152(5):1009\u201314.","journal-title":"Br J Dermatol"},{"key":"2870_CR75","first-page":"35","volume":"53","author":"B Daniel","year":"2012","unstructured":"Daniel B, Mendoza C, Intong L, Harris G, Rhodes L, Murrell D. Multi-disciplinary approach in the management of adult patients with epidermolysis bullosa. Australas J Dermatol. 2012;53:35.","journal-title":"Australas J Dermatol"},{"issue":"5","key":"2870_CR76","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1111\/jdv.15371","volume":"33","author":"S D\u0103nescu","year":"2019","unstructured":"D\u0103nescu S, S\u0103l\u0103v\u0103stru C, Sendrea A, Tiplica S, Baican A, Ungureanu L, et al. Correlation between disease severity and quality of life in patients with epidermolysis bullosa. J Eur Acad Dermatol Venereol. 2019;33(5):e217\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2870_CR77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13023-019-1059-8","volume":"14","author":"J Chan","year":"2019","unstructured":"Chan J, Weisman A, King A, Maksomski S, Shotwell C, Bailie C, et al. Occupational therapy for epidermolysis bullosa: clinical practice guidelines. Orphanet J Rare Dis. 2019;14(1):129.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2870_CR78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/pde.12262","volume":"31","author":"E Eismann","year":"2014","unstructured":"Eismann E, Lucky A, Cornwall R. Hand function and quality of life in children with epidermolysis bullosa. Pediatr Dermatol. 2014;31(2):176\u201382.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"2870_CR79","first-page":"e262","volume":"25","author":"D Pe\u00f1arrocha-Oltra","year":"2020","unstructured":"Pe\u00f1arrocha-Oltra D, Agust\u00edn-Panadero R, Serra-Pastor B, Pe\u00f1arrocha-Diago M, Pe\u00f1arrocha-Diago M. Oral rehabilitation with dental implants in patients with recessive dystrophic epidermolysis bullosa: a retrospective study with 2\u201315 years of follow-up. Med Oral Patol Oral Cir Bucal. 2020;25(2):e262\u20137.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"2870_CR80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijwd.2015.08.002","volume":"23","author":"C Chaptini","year":"2015","unstructured":"Chaptini C, Casey G, Harris A, Wattchow D, Gordon L, Murrell D. Botulinum toxin a injection for chronic anal fissures and anal sphincter spasm improves quality of life in recessive dystrophic epidermolysis bullosa. Int J Womens Dermatol. 2015;23(1):167\u20139.","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"2870_CR81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/pde.12243","volume":"31","author":"A Kirkorian","year":"2014","unstructured":"Kirkorian A, Weitz N, Tlougan B, Morel K. Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity. Pediatr Dermatol. 2014;31(1):33\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"2870_CR82","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaad.2020.03.028","volume":"85","author":"V Eng","year":"2021","unstructured":"Eng V, Solis D, Gorell E, Choi S, Nazaroff J, Li S, et al. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: a global cross-sectional survey. J Am Acad Dermatol. 2021;85(5):1161\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2870_CR83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13023-017-0666-5","volume":"12","author":"J Brun","year":"2017","unstructured":"Brun J, Chiaverini C, Devos C, Leclerc-Mercier S, Mazereeuw J, Bourrat E, et al. Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet J Rare Dis. 2017;12(1):119.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2870_CR84","first-page":"34","volume":"5","author":"O Riga","year":"2018","unstructured":"Riga O, Trofimov I, Kurilina T. Nutritional disorders in children with life-limiting diseases in developing country. Cogent Med. 2018;5(1):34.","journal-title":"Cogent Med"},{"key":"2870_CR85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1440-0960.2012.00918.x","volume":"54","author":"J Frew","year":"2013","unstructured":"Frew J, Cepeda-Valdes R, Fortuna G, Salas-Alanis J, Murrell D. Cross cultural adaptation of the \u2019quality of life in epidermolysis bullosa (QOLEB) questionnaire: validation and results of a Hispanic translation. Australas J Dermatol. 2013;54:39\u201340.","journal-title":"Australas J Dermatol"},{"issue":"1","key":"2870_CR86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.12885","volume":"171","author":"J Snauwaert","year":"2014","unstructured":"Snauwaert J, Yuen W, Jonkman M, Moons P, Naulaers G, Morren M. Burden of itch in epidermolysis bullosa. Br J Dermatol. 2014;171(1):73\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"2870_CR87","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"J Tang","year":"2021","unstructured":"Tang J, Marinkovich M, Lucas E, Gorell E, Chiou A, Lu Y, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021;16(1):175.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2870_CR88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13023-020-01640-0","volume":"16","author":"A King","year":"2021","unstructured":"King A, Hanley H, Popenhagen M, Perez F, Thompson K, Purvis D, et al. Supporting sexuality for people living with epidermolysis bullosa: clinical practice guidelines. Orphanet J Rare Dis. 2021;16(1):9.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2870_CR89","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/bjd.20809","volume":"186","author":"D Greenblatt","year":"2021","unstructured":"Greenblatt D, Pillay E, Snelson K, Saad R, Torres Pradilla M, Widhiati W, et al. Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline. Br J Dermatol. 2021;186(4):620\u201332.","journal-title":"Br J Dermatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02870-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02870-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02870-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T12:29:57Z","timestamp":1700310597000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02870-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2870"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02870-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"With two exceptions (K.M.C and GS.), this panel of researchers has no financial conflicts of interest. K.M.C. declared a potential conflict from her professional work coordinating guidelines for DEBRA International. GS declared a potential conflict from his NICHD-funded postdoctoral fellowship (T32GM008562). Therefore, neither of these authors were involved in the final recommendation editions of the manuscript or post review panel feedback (see Additional file 3 for panel involved and roles). All reviewers declared that they have no potential conflicts of interest with respect to the publication of this guideline.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}